SINGAPORE - The Monetary Authority of Singapore (MAS) and the People’s Bank of China (PBC) are planning to advance cooperation in green and transition finance between China and Singapore. The central ...
Billion-dollar money laundering case: Suspect gets new charges of using forged papers, having criminal proceeds
SINGAPORE: Lin Baoying, the only woman among 10 suspects in Singapore's multibillion-dollar money-laundering investigation, was on Tuesday (May 21) handed seven new charges. The new charges are ...
Singapore’s ThinKuvate Targets Indian Startups With Maiden INR 100 Cr Fund
The average investment size from the new fund is likely to be up to INR 3 Cr. They plan to invest in 12 -15 startups in a year ...
MAS, People’s Bank of China further collaboration in green and transition finance
The Monetary Authority of Singapore (MAS) and the People’s Bank of China (PBC) discussed initiatives to advance cooperation in green and transition finance between China and Singapore at the 2nd China ...
Singapore faces new COVID-19 wave
Singapore is facing a new COVID-19 wave with a surge in infection cases in the last two weeks, according to Health Minister Ong Ye Kung.
AstraZeneca Announces $1.5 Billion Investment in Manufacturing Facility in Singapore
AstraZeneca’s ambitious plan to construct a $1.5 billion manufacturing facility in Singapore heralds a new chapter in the company’s quest to bolster its global supply of cancer-fighting medications.
AstraZeneca to build $1.5bn ADCs facility in Singapore
Pharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug conjugates (ADCs) manufacturing facility in Singapore.
AstraZeneca unveils plan for $1.5bn ADC plant in Singapore
AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to manufacture them.
Singapore Market ends flat
At closing bell, the Straits Times Index (STI) index edged up 0.57 point, or 0.02% to 3,314.05 after trading between 3,306.32 and 3,318.24. Across the broader market, advancers outpaced decliners 333 ...
STI ends almost flat as market faces reality check
Market watchers said all eyes remain on China, and Asian markets are likely to take their cue from the global economic powerhouse. Mixed macroeconomic data from China shows that the country’s recovery ...
Pine Labs Awaits India Nod For Reverse Flip After Singapore Approval
Singapore-based Pine Labs Limited (PLS) will merge with its Indian counterpart Pine Labs Private Limited as part of the reverse flipping. While the company has received t ...
AstraZeneca to build $1.5 billion cancer drug manufacturing plant in Singapore
AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish ...
Trust Bank’s 0% FX Fees Result in Over S$18 Million in Customer Savings
Trust Bank's users saved over S$18 million on foreign currency transactions in the past year, thanks to its 0% foreign exchange fee policy.
Astrazeneca to build huge new cancer drug plant in Singapore
Astrazeneca is investing $1.5bn to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment.
AstraZeneca plans to build $1.5 billion manufacturing facility in Singapore
AstraZeneca said on Monday it plans to build a $1.5 billion manufacturing facility in Singapore in an effort to enhance its antibody drug conjugates (ADCs) portfolio. The greenfield facility, which ...
AstraZeneca to build US$1.5 billion cancer drug plant in Singapore, reduce industry’s reliance on China
CEO Pascal Soriot is working to ensure AstraZeneca can independently supply drugs to major markets as the US pushes to reduce the industry’s reliance on China.